Eric Salazar

Eric Salazar, MD, PhD

Adjunct Associate Professor of Pathology and Genomic Medicine, Academic Institute
Associate Affiliate Member, Research Institute
Houston Methodist


Publications

Direct oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor-specific anti-Xa concentrations
Dinunno, CV, Lopez, CN, Succar, L, Nguyen, DT, Graviss, EA, Salazar, E & Donahue, KR 2022, , Pharmacotherapy, vol. 42, no. 10, pp. 768-779. https://doi.org/10.1002/phar.2726

Recurrent Gastrointestinal Bleeding in a Middle-Aged Man
Gowani, F, Phillips, B, Leveque, C, Castillo, B, Chen, J, Chandler, W, Rice, L & Salazar, E 2022, , Laboratory Medicine, vol. 53, no. 4, pp. e91-e94. https://doi.org/10.1093/labmed/lmab104

Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee
Metcalf, RA, Cohn, CS, Allen, ES, Bakhtary, S, Gniadek, T, Gupta, G, Harm, S, Haspel, R, Hess, A, Jacobson, J, Lokhandwala, PM, Murphy, C, Poston, J, Prochaska, MT, Raval, JS, Saifee, NH, Salazar, E, Shan, H, Zantek, N & Pagano, MB 2022, , Transfusion, vol. 62, no. 7, pp. 1435-1445. https://doi.org/10.1111/trf.16944

Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy
Chen, J, Nguyen, S, Ruegger, M, Samuel, L, Salazar, E & Dunne, I 2022, , Journal of Thrombosis and Thrombolysis, vol. 54, no. 2, pp. 260-267. https://doi.org/10.1007/s11239-022-02650-4

Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program
Salazar, E, Long, TA, Smock, KJ, Wool, GD, Rollins-Raval, M, Chen, D, Harris, NS, Chan, CW, Olson, JD, Pham, HP, Ritter, J, Unold, D, Vansandt, AM & Goodwin Iv, AJ 2022, , Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/s-0042-1749591

Carboxyhemoglobinemia in critically ill coronavirus disease 2019 patients
Faisal, H, Ali, ST, Xu, J, Nisar, T, Sabawi, M, Salazar, E & Masud, FN 2021, , journal of clinical medicine, vol. 10, no. 12, 2731. https://doi.org/10.3390/jcm10122731

Carboxyhemoglobinemia in critically ill coronavirus disease 2019 patients
Faisal, H, Ali, ST, Xu, J, Nisar, T, Sabawi, M, Salazar, E & Masud, FN 2021, , Journal of Clinical Medicine, vol. 10, no. 12, 2731. https://doi.org/10.3390/jcm10122731

The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
Klassen, SA, Senefeld, JW, Johnson, PW, Carter, RE, Wiggins, CC, Shoham, S, Grossman, BJ, Henderson, JP, Musser, J, Salazar, E, Hartman, WR, Bouvier, NM, Liu, STH, Pirofski, LA, Baker, SE, van Helmond, N, Wright, RS, Fairweather, DL, Bruno, KA, Wang, Z, Paneth, NS, Casadevall, A & Joyner, MJ 2021, , Mayo Clinic Proceedings, vol. 96, no. 5, pp. 1262-1275. https://doi.org/10.1016/j.mayocp.2021.02.008

Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
Gontu, A, Srinivasan, S, Salazar, E, Nair, MS, Nissly, RH, Greenawalt, D, Bird, IM, Herzog, CM, Ferrari, MJ, Poojary, I, Katani, R, Lindner, SE, Minns, AM, Rossi, R, Christensen, PA, Castillo, B, Chen, J, Eagar, TN, Yi, X, Zhao, P, Leveque, C, Olsen, RJ, Bernard, DW, Gollihar, J, Kuchipudi, SV, Musser, JM & Kapur, V 2021, , Communications Biology, vol. 4, no. 1, 267. https://doi.org/10.1038/s42003-021-01813-y

Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
Salazar, E, Christensen, PA, Graviss, EA, Nguyen, DT, Castillo, B, Chen, J, Lopez, BV, Eagar, TN, Yi, X, Zhao, P, Rogers, J, Shehabeldin, A, Joseph, D, Masud, F, Leveque, C, Olsen, RJ, Bernard, DW, Gollihar, J & Musser, JM 2021, , American Journal of Pathology, vol. 191, no. 1, pp. 90-107. https://doi.org/10.1016/j.ajpath.2020.10.008

Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection
Liu, X, Wang, YL, Wu, J, Qi, J, Zeng, Z, Wan, Q, Chen, Z, Manandhar, P, Cavener, VS, Boyle, NR, Fu, X, Salazar, E, Kuchipudi, SV, Kapur, V, Zhang, X, Umetani, M, Sen, M, Willson, RC, Chen, SH & Zu, Y 2021, , Angewandte Chemie - International Edition, vol. 60, no. 18, pp. 10273-10278. https://doi.org/10.1002/anie.202100345

Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events
Nguyen, SN, Ruegger, MC, Salazar, E, Dreucean, D, Tatara, AW & Donahue, KR 2021, , Journal of Pharmacy Practice. https://doi.org/10.1177/08971900211009075

Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series
Morton, C, Lista, A, Jakowenko, N, Salazar, E & Donahue, KR 2022, , Journal of Thrombosis and Thrombolysis, vol. 53, no. 1, pp. 235-239. https://doi.org/10.1007/s11239-021-02521-4

Ultrasound-based criteria for adequate peripheral venous access in therapeutic apheresis procedures
Salazar, E, Gowani, F, Segura, F, Passe, H, Seamster, L, Chapman, B, Joubert, F, Hopson, S, Easley, T, Garcia, S, Miguel, R, Medina, C, Musharbash, A, Castillo, B, Chen, J, Ipe, T & Leveque, C 2021, , Journal of Clinical Apheresis, vol. 36, no. 6, pp. 797-801. https://doi.org/10.1002/jca.21930

Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury
Towers, W, Nguyen, SN, Ruegger, MC, Salazar, E & Donahue, KR 2021, , Annals of Pharmacotherapy. https://doi.org/10.1177/10600280211046087

Real-world Assessment of 2879 COVID-19 Patients Treated With Monoclonal Antibody Therapy: A Propensity Score–Matched Cohort Study
Cooper, MH, Christensen, PA, Salazar, E, Perez, KK, Graviss, EA, Nguyen, D, Musser, JM, Huang, HJ & Liebl, MG 2021, , Open Forum Infectious Diseases, vol. 8, no. 11, ofab512. https://doi.org/10.1093/ofid/ofab512

Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
Salazar, E, Kuchipudi, SV, Christensen, PA, Eagar, T, Yi, X, Zhao, P, Jin, Z, Long, SW, Olsen, RJ, Chen, J, Castillo, B, Leveque, C, Towers, D, Lavinder, J, Gollihar, J, Cardona, J, Ippolito, G, Nissly, R, Bird, I, Greenawalt, D, Rossi, RM, Gontu, A, Srinivasan, S, Poojary, I, Cattadori, IM, Hudson, PJ, Josleyn, NM, Prugar, L, Huie, K, Herbert, A, Bernard, DW, Dye, JM, Kapur, V & Musser, JM 2020, , Journal of Clinical Investigation, vol. 130, no. 12, pp. 6728-6738. https://doi.org/10.1172/JCI141206

Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
Salazar, E, Christensen, PA, Graviss, EA, Nguyen, DT, Castillo, B, Chen, J, Lopez, BV, Eagar, TN, Yi, X, Zhao, P, Rogers, J, Shehabeldin, A, Joseph, D, Masud, F, Leveque, C, Olsen, RJ, Bernard, DW, Gollihar, J & Musser, JM 2021, , American Journal of Pathology, vol. 191, no. 1, pp. 90-107. https://doi.org/10.1016/j.ajpath.2020.10.008, https://doi.org/10.1016/j.ajpath.2020.10.008

Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
Salazar, E, Christensen, PA, Graviss, EA, Nguyen, DT, Castillo, B, Chen, J, Lopez, BV, Eagar, TN, Yi, X, Zhao, P, Rogers, J, Shehabeldin, A, Joseph, D, Leveque, C, Olsen, RJ, Bernard, DW, Gollihar, J & Musser, JM 2020, , American Journal of Pathology, vol. 190, no. 11, pp. 2290-2303. https://doi.org/10.1016/j.ajpath.2020.08.001

Evidence favoring the efficacy of convalescent plasma for COVID-19 therapy
Klassen, SA, Senefeld, JW, Johnson, PW, Carter, RE, Wiggins, CC, Shoham, S, Grossman, BJ, Henderson, JP, Musser, J, Salazar, E, Hartman, WR, Bouvier, NM, Liu, STH, Pirofski, LA, Baker, SE, van Helmond, N, Scott Wright, R, Fairweather, DL, Bruno, KA, Wang, Z, Paneth, NS, Casadevall, A & Joyner, MJ 2020, , Unknown Journal. https://doi.org/10.1101/2020.07.29.20162917